Cell growth regulatory and antiviral effects of the P69 isozyme of 2-5 (A) synthetase

Virology

Volumn 266, Issue 2, 2000, Pages 319-328

  Ghosh, Arundhati ^a   Sarkar, Saumendra N ^a   Sen, Ganes C ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; INTERFERON; ISOENZYME;

ANTIVIRAL ACTIVITY; ARTICLE; CELL GROWTH; CELL STRAIN; CONTROLLED STUDY; CYTOKINESIS; ENCEPHALOMYOCARDITIS VIRUS; ENDOPLASMIC RETICULUM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MULTINUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN INDUCTION; VIRUS INHIBITION;

ENCEPHALOMYOCARDITIS VIRUS; MAMMALIA; REOVIRUS SP.; SENDAI VIRUS; VESICULAR STOMATITIS VIRUS;

EID: 0034688305     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.0085     Document Type: Article

References (31)

1. Anderson S. L., Carton J. M., Lou J., Xing L., Rubin B. Y. Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus. Virology. 256:1999;8-14.
2. Chebath J., Benech P., Hovanessian A., Galabru J., Revel M. Four different forms of interferon-induced 2′,5′-oligo(A) synthetase identified by immunoblotting in human cells. J. Biol. Chem. 262:1987a;3852-3857.
3. Chebath J., Benech P., Revel M., Vigneron M. Constitutive expression of (2′-5′) oligo A synthetase confers resistance to picornavirus infection. Nature. 330:1987b;587-588.
4. Coccia E. M., Romeo G., Nissim A., Marziali G., Albertini R., Affabris E., Battistini A., Fiorucci G., Orsatti R., Rossi G. B. A full-length murine 2-5A synthetase cDNA transfected in NIH-3T3 cells impairs EMCV but not VSV replication. Virology. 179:1990;228-233.
5. Diaz-Guerra M., Rivas C., Esteban M. Inducible expression of the 2-5A synthetase/RNase L system results in inhibition of vaccinia virus replication. Virology. 227:1997;220-228.
6. Ghosh A., Sarkar S. N., Guo W., Bandyopadhyay S., Sen G. C. Enzymatic activity of 2′-5′-oligoadenylate synthetase is impaired by specific mutations that affect oligomerization of the protein. J. Biol. Chem. 272:1997;33220-33226.
7. Ghosh S. K., Kusari J., Bandyopadhyay S. K., Samanta H., Kumar R., Sen G. C. Cloning, sequencing, and expression of two murine 2′-5′-oligoadenylate synthetases: Structure-function relationships. J. Biol. Chem. 266:1991;15293-15299.
8. Gribaudo G., Lembo D., Cavallo G., Landolfo S., Lengyel P. Interferon action: Binding of viral RNA to the 40-kilodalton 2′-5′-oligoadenylate synthetase in interferon-treated HeLa cells infected with encephalomyocarditis virus. J. Virol. 65:1991;1748-1757.
9. Ichii Y., Fukunaga R., Shiojiri S., Sokawa Y. Mouse 2-5A synthetase cDNA: Nucleotide sequence and comparison to human 2-5A synthetase. Nucleic Acids Res. 14:1986;10117.
10. Jin D. Y., Spencer F., Jeang K. T. Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell. 93:1998;81-91.
11. Kochs G., Haller O. Interferon-induced human MxA GTPase blocks nuclear import of Thogoto virus nucleocapsids. Proc. Natl. Acad. Sci. U S A. 96:1999;2082-2086.
12. Marie I., Hovanessian A. G. The 69-kDa 2-5A synthetase is composed of two homologous and adjacent functional domains. J. Biol. Chem. 267:1992;9933-9939.
13. Marie I., Rebouillat D., Hovanessian A. G. The expression of both domains of the 69/71 kDa 2′,5′ oligoadenylate synthetase generates a catalytically active enzyme and mediates an anti-viral response. Eur. J. Biochem. 262:1999;155-165.
14. Marie I., Svab J., Robert N., Galabru J., Hovanessian A. G. Differential expression and distinct structure of 69- and 100-kDa forms of 2-5A synthetase in human cells treated with interferon. J. Biol. Chem. 265:1990;18601-18607.
15. Meurs E. F., Watanabe Y., Kadereit S., Barber G. N., Katze M. G., Chong K., Williams B. R., Hovanessian A. G. Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth. J. Virol. 66:1992;5804-5814.
16. Rebouillat D., Hovanessian A. G. The human 2′,5′-oligoadenylate synthetase family: Interferon-induced proteins with unique enzymatic properties. J. Interfer. Cytokine Res. 19:1999;295-308.
17. Rutherford M. N., Kumar A., Nissim A., Chebath J., Williams B. R. The murine 2-5A synthetase locus: Three distinct transcripts from two linked genes. Nucleic Acids Res. 19:1991;1917-1924.
18. Rysiecki G., Gewert D. R., Williams B. R. Constitutive expression of a 2′,5′-oligoadenylate synthetase cDNA results in increased antiviral activity and growth suppression. J. Interfer. Res. 9:1989;649-657.
19. Sarkar S. N., Bandyopadhyay S., Ghosh A., Sen G. C. Enzymatic characteristics of recombinant medium isozyme of 2′-5′ oligoadenylate synthetase. J. Biol. Chem. 274:1999a;1848-1855.
20. Sarkar S. N., Ghosh A., Wang H. W., Sung S. S., Sen G. C. The nature of the catalytic domain of 2′-5′ oligoadenylate synthetases. J. Biol. Chem. 274:1999b;25535-25542.
21. Sarkar S. N., Sen G. C. Production, purification, and characterization of recombinant 2′, 5′-oligoadenylate synthetases. Methods. 15:1998;233-242.
22. Silverman R. H. Fascination with 2-5A-dependent RNase: a unique enzyme that functions in interferon action. J. Interfer. Res. 14:1994;101-104.
23. Staeheli P., Haller O. Interferon-induced Mx protein: a mediator of cellular resistance to influenza virus. Interferon. 8:1987;1-23.
24. Staeheli P., Haller O., Boll W., Lindenmann J., Weissmann C. Mx protein: Constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus. Cell. 44:1986;147-158.
25. Stark G. R., Kerr I. M., Williams B. R., Silverman R. H., Schreiber R. D. How cells respond to interferons. Annu. Rev. Biochem. 67:1998;227-264.
26. Tirasophon W., Welihinda A. A., Kaufman R. J. A stress response pathway from the endoplasmic reticulum to the nucleus requires a novel bifunctional protein kinase/endoribonuclease (Ire1p) in mammalian cells. Genes Dev. 12:1998;1812-1824.
27. Vilcek, J., and Sen, G. C.1996. Interferons and other cytokines. InFields Virology (B. N. Fields, D. M. Knipe, and P. M. Howley, Eds.), pp. 375-399. Lippincott-Raven Publishers, Philadelphia.
28. Wang X. Z., Harding H. P., Zhang Y., Jolicoeur E. M., Kuroda M., Ron D. Cloning of mammalian Ire1 reveals diversity in the ER stress responses. EMBO J. 17:1998;5708-5717.
29. Yang Y. L., Reis L. F., Pavlovic J., Aguzzi A., Schafer R., Kumar A., Williams B. R., Aguet M., Weissmann C. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J. 14:1995;6095-6106.
30. Zhou A., Paranjape J., Brown T. L., Nie H., Naik S., Dong B., Chang A., Trapp B., Fairchild R., Colmenares C., Silverman R. H. Interferon action and apoptosis are defective in mice devoid of 2′,5′-oligoadenylate-dependent RNase L. EMBO J. 16:1997;6355-6363.
31. Zhou A., Paranjape J. M., Der S. D., Williams B. R., Silverman R. H. Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways. Virology. 258:1999;435-440.